SCHEMBL9696278

SCHEMBL9696278

CC(C)c1c(C(=O)O)c(-c2ccc(F)cc2)n2ccccc12

nearest known ligand 0.44

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 4/20 0.44
ALDH1A1 P00352 5/20 0.38
KMT2A Q03164 4/20 0.38
KDM4E B2RXH2 4/20 0.38
HPGD P15428 3/20 0.38
MEN1 O00255 3/20 0.38
GAA P10253 1/20 0.38
PTGS2 P35354 1/20 0.38
MAPT P10636 2/20 0.37
MAPK1 P28482 1/20 0.37
POLB P06746 1/20 0.36
HMGCR P04035 1/20 0.36
FLT3 P36888 1/20 0.36
AGTR1 P30556 1/20 0.36
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9697139 0.78 ALDH1A1 (0.41) ALDH1A1KMT2AKDM4EMEN1GAA
SCHEMBL9696134 0.78 GCGR (0.39) ALDH1A1KMT2AKDM4EHPGDMEN1
SCHEMBL9695120 0.77 KDM4E (0.46) IDO1ALDH1A1KMT2AKDM4EHPGD
SCHEMBL10691696 0.74 ALDH1A1 (0.36) ALDH1A1KMT2AKDM4EHPGDMEN1
SCHEMBL9752965 0.72 MAPK14 (0.43) ALDH1A1KMT2AMEN1PTGS2
SCHEMBL6241912 0.72 HMGCR (0.57) PTGS2HMGCR
SCHEMBL6327616 0.72 HMGCR (0.57) PTGS2HMGCR
SCHEMBL27635670 0.72 HMGCR (0.57) PTGS2HMGCR
SCHEMBL10679732 0.72 HMGCR (0.57) PTGS2HMGCR
SCHEMBL27860649 0.69 IDO1 (0.52) IDO1ALDH1A1KMT2AKDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5124453-A Treatment of corresponding aldehyde with lithium bis(tri-methylsilyl)amide E. R. SQUIBB & SONS, INC. (US) 1992-06-23 US disclosed
EP-0444532-A1 Phosphorus-containing HMG-CoA reductase inhibitors, new intermediates and method E.R. SQUIBB & SONS, INC. (US) 1991-09-04 EP disclosed
US-5025000-A Anticholesterol, antilipemic agents E. R. SQUIBB & SONS, INC. (US) 1991-06-18 US disclosed
EP-0265640-A2 Azaindole and indolizine derivatives, processes for their production and their use as pharmaceuticals SANDOZ AG (CH) 1988-05-04 EP disclosed